Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 9NET 7Gastrointestinal 7CNS 2Thoracic 1Sarcoma 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 851Lung Neoplasms 575Small Cell Lung Carcinoma 164Colorectal Neoplasms 130Breast Neoplasms 104Melanoma 100Neoplasms 91Ovarian Neoplasms 89Neoplasm Metastasis 82Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 68Stomach Neoplasms 59Carcinoma, Renal Cell 54Head and Neck Neoplasms 53Esophageal Neoplasms 48Triple Negative Breast Neoplasms 47Endometrial Neoplasms 47Prostatic Neoplasms 45Uterine Cervical Neoplasms 41Colonic Neoplasms 40Urinary Bladder Neoplasms 39Mesothelioma 38Carcinoma, Hepatocellular 35Mesothelioma, Malignant 34Brain Neoplasms 30Sarcoma 28Carcinoma, Transitional Cell 28Adenocarcinoma of Lung 28Lung Diseases 24Disease 24

Interventions

fludarabine phosphate 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoma, Islet Cell × Thoracic × 90 days × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡